Leukocytoclastic vasculitis (LCV) is an inflammatory condition that damages the smallest blood vessels in the skin, producing a distinctive rash of raised, reddish-purple spots that don’t fade when you press on them. It affects roughly 45 people per million each year, making it uncommon but far from rare. In most cases the rash resolves on its own within weeks, though some people develop chronic or recurring episodes that need ongoing treatment.
What Happens in the Blood Vessels
The name itself tells the story if you break it apart. “Leukocytoclastic” refers to the breakup of white blood cells called neutrophils, and “vasculitis” means inflammation of blood vessels. In LCV, the immune system deposits clusters of antibodies (called immune complexes) along the walls of small vessels in the skin. Neutrophils rush to the site and release enzymes meant to fight the perceived threat, but in the process they destroy themselves and the vessel walls around them.
Under a microscope, this produces three hallmarks: fragments of shattered neutrophil nuclei (sometimes called “nuclear dust”), deposits of a clotting protein called fibrin in and around the vessel wall, and red blood cells that have leaked out of the damaged vessels into surrounding tissue. That leakage of blood beneath the skin is what creates the visible rash.
Common Causes and Triggers
LCV is not a single disease so much as a pattern of damage that many different triggers can set off. In roughly half of cases, no clear cause is ever identified. When a cause is found, it typically falls into one of a few categories.
Medications are among the most common triggers. Antibiotics (particularly quinolones and clarithromycin), NSAIDs like ibuprofen, the diuretic furosemide, and biologic drugs used for autoimmune conditions have all been linked to LCV. Drug-induced cases usually appear one to three weeks after starting the medication, though the timeline can vary.
Infections are another frequent trigger, especially upper respiratory infections, hepatitis B, hepatitis C, and HIV. The immune complexes formed during the body’s fight against infection can lodge in small vessels and spark the same inflammatory cascade.
Autoimmune diseases such as lupus, rheumatoid arthritis, and Sjögren syndrome can produce LCV as a secondary complication. In these cases, the vasculitis tends to recur alongside flares of the underlying condition. Certain cancers, particularly blood cancers, are a less common but important trigger that doctors screen for in older adults with unexplained LCV.
What the Rash Looks and Feels Like
The signature finding is palpable purpura: small, raised spots ranging from a few millimeters to a centimeter across that appear red, purple, or rust-colored. Unlike a typical rash, these spots don’t blanch (turn white) when you press a finger or glass against them, because the color comes from blood that has escaped the vessels, not from dilated vessels near the surface.
The rash overwhelmingly favors the lower legs and ankles, which makes sense because gravity increases pressure in those small vessels. It can also appear on the buttocks and, less commonly, the trunk, arms, or face. The spots usually emerge in crops, meaning a batch appears over a day or two, and new crops may follow over several weeks. Some people experience mild burning, itching, or stinging at the affected areas, while others notice no discomfort at all.
In one specific subtype called IgA vasculitis (previously known as Henoch-Schönlein purpura), joint pain is extremely common, affecting more than 60% of adult patients. The knees and ankles are the joints most often involved, and the pain tends to appear on both sides of the body at once. IgA vasculitis is the most common form in children, occurring in up to 270 per million children annually, and it can also involve the kidneys and gut.
How It’s Diagnosed
A skin biopsy is the gold standard. A small punch of affected skin is taken (usually from a spot that appeared within the last 24 to 48 hours, when the characteristic changes are clearest) and examined under a microscope. The pathologist looks for the three features described above: neutrophil nuclear dust, fibrin deposits in vessel walls, and evidence of vessel damage with leaked red blood cells.
A second test called direct immunofluorescence (DIF) can be performed on the same biopsy sample to identify which types of antibodies are deposited in the vessel walls. This is especially useful for distinguishing general LCV from IgA vasculitis. In IgA vasculitis, 75% to 100% of skin biopsies show IgA antibody deposits. In non-IgA forms of LCV, overall antibody positivity is much lower, around 39%.
Looking for an Underlying Cause
Once the biopsy confirms LCV, the next step is figuring out why it happened. Your doctor will typically review any medications started in the weeks before the rash appeared. Blood and urine tests help screen for infections, autoimmune conditions, and kidney involvement. A complete blood count, kidney function tests, liver panel, urinalysis, and tests for hepatitis B and C are standard parts of this workup. If an autoimmune disease is suspected, additional antibody tests may be ordered.
This screening matters because LCV that looks like a skin-only problem can occasionally signal something deeper. Kidney involvement, in particular, needs to be caught early because it can cause lasting damage if untreated.
Treatment and What to Expect
For a single episode with a clear trigger, the main treatment is removing that trigger. If a medication caused it, stopping the drug usually leads to clearance of the rash within weeks. If an infection was the catalyst, treating the infection addresses the root cause. Supportive measures like leg elevation, compression stockings, and avoiding prolonged standing help reduce the pressure in lower-leg vessels and speed healing.
When the rash is severe, widespread, or accompanied by significant discomfort, a short course of oral corticosteroids can tamp down the inflammation quickly. The catch is that symptoms sometimes flare back when the steroid dose is tapered, which is why steroids alone aren’t ideal for chronic or recurring cases.
For people whose LCV keeps coming back or won’t resolve, colchicine and dapsone are the most commonly used first-line medications. Colchicine works by calming neutrophil activity, directly targeting the cells responsible for the vessel damage. Dapsone suppresses the inflammatory response through a different pathway, and combining the two sometimes works better than either alone. A third option, pentoxifylline, improves blood flow through small vessels and can be used alongside other treatments.
If the disease still flares whenever steroids are reduced, stronger immune-suppressing medications like methotrexate, azathioprine, or mycophenolate may be considered. These carry more significant side effects and require regular blood monitoring, so they’re reserved for the most stubborn cases.
Outlook and Recovery Timeline
Most episodes of LCV are self-limited, meaning the rash resolves on its own or shortly after the trigger is removed. A typical single episode clears within two to four weeks, though brownish discoloration at the sites of old spots can linger for months as the leaked blood pigment is slowly reabsorbed.
Chronic or relapsing LCV is less common but does happen, particularly when an underlying autoimmune condition is driving it. In these cases, the goal shifts from curing a single episode to keeping flares infrequent and mild with the lowest effective level of medication. People with LCV limited to the skin generally do well long-term. Those with systemic involvement, especially kidney disease in IgA vasculitis, need closer follow-up to monitor organ function over time.